JPRN-UMIN000014306已完成未知
Efficacy and safety of Ipragliflozin in patients with type 2 diabetes who have inadequate glycemic control. - Efficacy and safety of Ipragliflozin in patients with type 2 diabetes who have inadequate glycemic control.
akakinen clinic0 个研究点目标入组 100 人开始时间: 2014年6月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Type-1 diabetes, diabetes due to a pancreatic disorder, or secondary diabetes due to conditions (2) Application of contraindications contained in the package insert (3) Severe renal function disorder (4 )BMI is < 22kg/m2 (5) Under treatment with insulin,GLP-1 analog,or SGLT-2 inhibitor (6) Pregnant women, women suspected of being pregnant, or lactating women (7) Participation in the study is judged by the investigator or sub-investigator as inappropriate for any other reason
研究者
相似试验
尚未招募
不适用
Efficacy and Safety of Ipragliflozin, a selective SGLT2 inhibitor, in type 2 diabetes patients with insulin therapytype 2 diabetesJPRN-UMIN000014968Tokyo Medical University Hospital Division of Diabetes,Metabolism and Endocrinology50
尚未招募
4 期
Efficacy and Safety of empagliflozin in patients with hepatic ascites: a randomized controlled trialDigestive SystemPACTR202402866059449one60
已完成
不适用
A study on the efficacy and safety of ipragliflozin monotherapy or combination therapy under clinical use condition: continuous glucose monitoring and self monitoring of urine glucoseType 2 diabetesJPRN-UMIN000014388Kato clinic of Internal medicine30
尚未招募
不适用
Efficacy and safety of luseogliflozin in patient with type 2 diabetes complicated with hepatic dysfunctioType 2 diabetesJPRN-UMIN000025808Seino Internal Medicine Clinic50
已完成
4 期
Comparison of efficacy of ipraglifrozine and high-dose metformin in patients with type 2 diabetesJPRN-UMIN000014963Hokkaido University Hospital150